Company Registration No. 06853971 Charity No. 1134589
British and Irish Association of Stroke Physicians
Company Limited by Guarantee
Unaudited financial statements for the year ended 31 March 2024
British and Irish Association of Stroke Physicians Company Limited by Guarantee Contents
| Page | |
|---|---|
| Trustees' annual report | 1 - 8 |
| Independent examiner's report | 9 |
| Statement of financial activities (including Income and Expenditure account) | 10 |
| Statement of financial position | 11 |
| Notes to the financial statements | 12-18 |
British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) For the year ended 31 March 2024
The trustees, who are also the directors for the purposes of company law, present their report and the unaudited financial statements of the charity for the year ended 31 March 2024.
Reference and administrative details
| Registered charity name | British and Irish Association of Stroke Physicians |
|---|---|
| Company number | 06853971 |
| Charity number | 1134589 |
| Trustees | Dr Elizabeth Warburton |
| Professor Rustam Al-Shahi Salman - resigned 4 December 2023 | |
| Professor David Werring | |
| Professor Gillan Mead | |
| Dr Ganesh Subramian | |
| Dr Louise Shaw - appointed 4 December 2023 | |
| President | Professor David Werring |
| Secretary | Dr Ganesh Subramian |
| Registered office | 71 Queen Victoria Street |
| London | |
| England | |
| EC4V 4BE | |
| Principleoffice | Fitwise Management Limited |
| Blackburn House | |
| Seafield | |
| West Lothian | |
| EH47 7AQ | |
| Bankers | Bank of Scotland Plc |
| 43 Comely Bank | |
| Edinburgh | |
| EH4 1AF | |
| Independentexaminer | Kenneth McDowell CA |
| Saffery LLP | |
| Edinburgh Quay | |
| 133 Fountainbridge | |
| Edinburgh | |
| EH3 9BA |
1
British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024
Structure, governance and management
British Association of Stroke Physicians (BASP) was set up in April 1999 to promote better care for people with stroke in the UK. In December 2021 BASP became BIASP (British and Irish Association of Stroke Physicians) following consultation with membership and ratification at the 2021 AGM to include the Republic of Ireland. The five objectives of BIASP are:
- Clinical Standards
• Teaching & Training
• Research
• External Engagement
• Administration of the Association
BIASP, formerly know as BASP, is a charitable company limited by guarantee (Company No. 06853971), incorporated on 20 March 2009, and registered as a charity on 02 March 2010. The company was established under a Memorandum of Association, which established th e objects and powers of the charitable company and is governed under its Articles of Association. In the event of the company being wound up, members are required to contribute an amount not exceeding £1. The charitable company operates from the following address:
Blackburn House
Redhouse Road Bathgate West Lothian EH47 7AQ
BIASP Executive Committee April 2023 to March 2024:
-
President: Professor David Werring Dec 2023 - Dec 2025
-
President: Professor Gillian Mead Dec 2021 - Dec 2023
-
Past President: Professor Rustam Al-Shahi Salman Dec 2021 - Dec 2023
-
Past President: Professor Gillian Mead Dec 2023 - Dec 2025
-
President Elect: Professor David Werring Dec 2021 - Dec 2023
-
President Elect: Dr Louise Shaw Dec 2023 - Dec 2025
-
Secretary: Dr. Ganesh Subramanian Dec 2021 - Dec 2024
-
Deputy Secretary: Dr Mary Joan MacLeod Dec 2021 - Dec 2024
-
Treasurer: Dr Elizabeth Warburton
-
External Engagement Lead : Dr Jason Appleton (May 2023)
-
Sustainability Lead: Dr Bethan Davies
-
Equality Diversity and Inclusivity Lead: Dr Soma Banerjee
-
Chair Scientific Subcommittee: Dr Abhijit Das
-
Chair Training and Education Subcommittee: Dr Louise Shaw (stepped down Dec 2023)
-
Chair Training and Education Subcommittee: Dr Saugata Das (Jan 2024)
-
Chair Clinical Standards Subcommittee: Dr Michelle Dharmasiri
-
Chair Trainee Subcommittee: Dr Isuru Induruwa (stepped down April 2023)
-
Chair Trainee Subcommittee: Dr Gordon Blair (from April 2023)
-
Vice-chair Trainee Subcommittee: Dr Shyam Kelavkar (from April 2024)
-
Executive Member representing Wales: Dr Tom Hughes (2nd term ended Dec 2023)
-
Executive Member representing Wales: Dr Tal Anjum (from Dec 2023)
-
Executive Member representing Northern Ireland: Dr Patricia Fearon (stepped down Sept 2023)
-
Executive Member representing Scotland Member: Dr Terry Quinn ((2nd term ended Dec 2023)
-
Executive Member representing Scotland Member: Dr Vera Coro (from Dec 2023)
-
Executive Member representing England Member: Dr Melanie Blake
-
Executive Member representing England Member: Dr Becky Jupp
-
Executive Member representing Republic of Ireland: Prof Margaret O'Connor
-
Specialty and Associate Specialist Doctor: Dr Sohaa Jamil (from March 2024)
Scientific Subcommittee April 2023- March 2024
-
Chairman: Dr Abhijit Das
-
Member: Prof Craig Smith
-
Member: Dr Will Whiteley (term ended Dec 2023)
-
Member: Dr Phil Clatworthy (term ended Dec 2023)
-
Member: Dr Jonathan Hewitt (term ended Dec 2023)
-
Member: Alastair Webb
-
Member: Azmil Abdul-Rahim (Dec 2023)
-
Trainee Representative: Dr Joseph Pybus
2
British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024
Clinical Standards Subcommittee April 2023- March 2024
-
Chairman: Dr. Michelle Dharmasiri
-
Member: Dr Kath Pasco
-
Member: Dr Jatt Khaira
-
Member: Dr Eiman Abdelgadir
-
Member: Dr Kamy Thavanesan
-
Member: Dr Joseph Kwan (Jan 23)
-
Co-opted Member: Dr Fergus Doubal
-
Trainee Representative: Dr Ahmed Gabr
Training & Education Subcommittee April 2023 - March 2024
-
Chairman: Dr Louise Shaw (stepped down Dec 2023)
-
Chairman: Dr Saugata Das (Jan 2024)
-
Member: Dr James Choulerton
-
Member: Dr Senthil Raghunathan
-
Member: Dr Sarita Sochart
-
Member: Dr Jessica Beavan
-
Trainee Representative: Dr David McShane
-
Trainee Representative: Dr Timothy Atkinson
Trainee Subcommittee April 2023 - March 2024
-
Chairman: Dr Isuru Induruwa (stepped down Mar 23)
-
Chairman: Dr Gordon Blair (April 2024)
-
Vice-chairman: Dr Shyam Kelavkar (April 2024)
-
Member: Dr Joseph Pybus
-
Member: Stewart McKenna
-
Member: Dr Karina Bennett (stepped down June 2023)
-
Member: Dr Ahmed Gabr
-
Member: Dr Alan Cameron
-
Member: Dr David McShane
-
Member: Dr Timothy Atkinson
3
British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024
BIASP Overview
BASP consulted its members in 2021 regarding adding the Republic of Ireland to the Association name and activities. It was voted in favour by members. BASP (British Association of Stroke Physicians) amended its name to BIASP (British and Irish Association of Stroke Physicians following the December 2021 AGM.
The British Association of Stroke Physicians (BASP) was established in 1999 to promote the advancement of stroke medicine within Great Britain. Our members are all practicing doctors who care for patients with stroke, with the aim of providing the highest standard of care. We value our diverse membership including physicians from a range of backgrounds and clinical roles. Some stroke physicians look after patients th roughout the pathway, while others have expertise in a particular specialist area. Some stroke physicians provide care exclusively for patients wit h TIA/stroke, whilst others provide care to patients from their parent specialty: for example, general medicine, geriatric medicine, neurology or rehabilitation medicine. Many of our members have academic roles in stroke research. Our members also contribute to continuously improving the quality of stro ke care according to the best available evidence.
BASP was formed with a less than full-time administrator and a modest membership fee. Over almost two decades, BASP has made considerable progress. The membership has grown. Scientific meetings have occurred every year. BASP was a founding major coalition partner in the UK Stroke Forum, and the BASP annual scientific meeting has merged into the UK Stroke Forum coalition's annual conference. BASP participated in developing and leading the NIHR stroke research network. BASP members participated in developing and delivering major evidence-based improvements in the care of people with stroke and at risk of stroke. BASP also helped to establish stroke medicine as a sub-speciality. During this time, an elected, un-paid executive committee has directed and conducted BASP's activities. This BIASP executive committee currently comprises 18 people: President, Past President, President Elect, Honorary Secretary, Deputy Honorary Secretary, Honorary Treasurer, External Engagement Lead, Sustainability Lead, Equality, Diversity and Inclusion Lead, Scientific subcommittee chair, Trainees subcommittee chair, Training and Education subcommittee chair, Clinical Standard subcommittee chair, National Representatives (one for Wales, Scotland, and Northern Ireland, Republic of Ireland and two for England).
The BIASP executive committee is supported by members of the subcommittees.
BIASP strategic direction
BIASP's mission of 'advancing stroke medicine' for the good of the public, patients and professionals is guided by a strategic plan, a new plan was put in place for 2021 - 2024.
During the spring and summer of 2020, the BASP executive committee chairs and BASP President reviewed BASP's progress and execution of the aims of the BASP strategy during 2017-2020. We found clear evidence of satisfying almost all of the aims of the BASP strategy 2017-2020.
Following this review of the execution of the 2017-2020 strategy, the president drafted this quadrennial update of the strategic plan with input from the executive committee (18 May - 6 October 2020). The president created the final version of the strategic plan 2021-2024 following a consultation with the public (via the BASP website), relevant stroke organisations (who were alerted via email) and BASP full, associate, and retired members between 6-30 October 2020.
The consultation yielded responses from five organisations (Intercollegiate Stroke Working Party, Different Strokes, Association of British Neurologists stroke advisory group, British Cardiovascular Society, and The Stroke Association) and 17 individuals via an online form or email. This strategic plan 2021-2024 was launched after the president presented it at the annual general meeting on 8 December 2020.
The BIASP strategy 2021 - 2024 included five main areas of focus:
-
Clinical Standards Service
-
Teaching and Training
-
Research
-
External Engagement
-
Administration of the Association
Each of these areas has a number of defined objectives, these can be viewed via the strategy hosted on the BIASP website.
Moving Forward
All future actions are aligned with the 2021 - 2024 strategy. The 2025 - 2028 strategy refresh is being developed by the BIASP President following consultation with the BIASP Executive committee.
BIASP are members of:
-
World Stroke Organisation (WSO)
-
European Stroke Organisation (ESO)
-
Neurological Alliance
-
Community rehabilitation alliance (CRA)
-
UK Health Alliance on Climate Change (UKHACC)
4
British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024
BIASP Meetings
The BIASP Executive meets monthly, three times during the year this is a 4-hour meeting, the other meetings last for one hour. The Executive oversee and provide direction to the Association, to determine the Association's strategy and support the work undertaken by the subc ommittees. The subcommittees meet virtually, on a quarterly basis.
BIASP have been working to develop closer relationships with other professional organisations including BGS (reciprocal joint membership reduction 20% discount for first year of membership), ABN, BSPRM, SAM, through regular meetings with the other societies' executives. A further joint membership reduction 20% discount for first year of membership has been agreed with BSPRM which will commence in 2024.
BIASP chair quarterly 5 Nation meetings. The clinical leads from each nation, BIASP executive leads for each nation and charities such as the Stroke Association, Different Strokes, Chest Heart & Stroke Scotland, Irish Heart Foundation and Northern Ireland Chest Heart &Stroke and British Heart Foundation are invited. A different topic is chosen for discussion each month with each participant sharing views.
BIASP are working with Covid -19 Airborne Transmission Alliance (CATA) and providing information for the UK-public inquiry into Covid.
BIASP Committee representation
BIASP also has formal representation on external committees. These are listed here:
| Group | BIASP Representative |
|---|---|
| Association of British Neurologists | BIASP President Elect & ABN SIG member |
| Joint Clinical | England Representative x2, trainee committee chair |
| Joint Neurosciences Council | Trainingand Education |
| Stroke Action Plan for Europe(SAP-E) | Clinical Standards Chair |
| Cross PartyWorkingGroupon Stroke | Scotland Representative and BIASP President |
| Intercollegiate Stroke | BIASP President-elect |
| Joint Stroke Medicine Committee | BIASP President Elect, BIASP Trainee and ED&I Lead |
| NHSE&I Stroke DeliveryBoard | England Representative |
| NIHR/BIASP UK Stroke Research | Scientific Committee Chair |
| NI Stroke Network | Northern Ireland Representative |
| Scotland Stroke Research Network | Scotland Representative |
BIASP Committee representation (continued)
| UKSF SteeringCommittee | BIASP President |
|---|---|
| UKSF Scientific Programme Committee | Scientific Committee Chair |
| Wales Association for Stroke Physicians | Wales Representative |
| Stroke SpecialityAdvisoryCommittee | Trainingand Education |
| Royal College of Radiologists MT | Clinical Standards Chair |
| British Geriatric Society | President & President Elect and ED&I Lead |
| National AdvisoryCommittee for Stroke | Scotland Representative |
| RCP Medical Specialties Board | BIASP President |
| NICE Stroke rehabguidance | Scientific subcommittee member |
| 5 Nations Meetings | BIASPpresident(or BIASP Past President or BIASP |
| Neurological Alliance | BIASP Past-President |
| UKHACC Council | BIASP President or BIASP Past-President, |
| CommunityRehabilitation Alliance | Clinical Standards Representative |
| ESQ- meetingwith national societies | President |
| SSNAP | President |
| ThrombectomyImplementation Group | Clinical Standards Chair and President(if available) |
Scientific Subcommittee
The Scientific subcommittee have been working on the following areas which align with the BIASP strategic plans:
- BIASP/NIHR- this is being launched in May 2024 with BIASP as the admin mechanism for this award from now
• Local Clinical Research Investigator Award, pilot with 2 winners, certificates and free registration for UKSF.
• BIASP Bulletin - the Subcommittee try to submit a varied set of articles covering research and surveys on areas and studies related to stroke.
• Qngoing review of their website page.
• UKSF 2023 -in-person event held in Birmingham, with the Scientific committee preparing the BIASP Programme content. The programme content also received contributions from the Scientific, Training and Education and Trainee subcommittee
• External engagement: The Scientific Subcommittee engage with the Stroke Association, BGS, BIHS, BIHR, NICE, NHSE. BGS.
The scientific committee is actively involved in the planning of the programme for the next UKSF.
BIASP/NIHR Writing groups are supported through a grant from BIASP, up to 4 awards £1k each (£4,000).
5
British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024
Training & Education Subcommittee The Training & Education Subcommittee have been involved in the following activities in addition to it's duty to the UKSF: The priorities for the Training & Education Subcommittee have been: • Provide excellent resources to support training and education in stroke medicine • Virtual Learning Hub - free monthly webinars with a variety of different topics and speakers, subcommittee member is chair of the webinars • UK & RQI Acute Stroke Simulation Course developed with initial pilot prior to course set up in St George's in February • Promoted UK & RQI Acute Stroke Simulation Course at UKSF with a soapbox session • Provide incentives to train in stroke medicine • Take Up Stroke programme • Medical student essay prize • Mentorship scheme training for clinicians and clinical academics continues with the latest ALS mentorship training completed in February. Next training in Qctober. Following completion of modules and ALS training sessions the trained mentors have been successfully match to mentees when required. • Designed poster for the BIASP stand at UKSF • Subcommittee update for the BIASP bulletin • Qngoing review of their website page Take up Stroke Fellows: • Cohort 2 has commenced, two workstreams agreed: education and sim training, both to encourage career in stroke • Regular updates are provided via the BIASP newsletter • The TUSF are engaging with medical schools with regards to how much stroke is included in their curriculum, 25% response to survey sent out to all UK & RQI medical schools • Invited representatives from NANSIG (Neurology and Neurosurgery Interest Group), who have 2000 student members at medical schools throughout the UK and RQI, to attend one of their meetings to develop a new relationship with BIASP to enthuse students to take up a career in stroke The Training and Education committee continue to be responsible for running monthly free webinars. These recordings are then made available to members post webinar via the BIASP website.
Clinical Standards Subcommittee
The Clinical Standards Subcommittee have been working on the following activities: • Coordinating BIASP workforce plan • Community rehab alliance, member of the subcommittee has been working on best practice recommendations • Review guidelines - these include: • NICE AI • Major Conditions Strategy • Clopidogrel • Tenecteplase • Workforce • SAP-E • Pre-hospital Special Interest Group • GIM and stroke CCT, 3 years - new stroke pathway • Guidelines - the committee continue to review these and update in the BIASP bulletin • Subcommittee update for the BIASP bulletin • Liaising with Boehringer Ingelheim Ltd re: alteplase shortage • Designed poster for the BIASP stand at UKSF • Qngoing review of their website page
Trainee Subcommittee
The Trainee Subcommittee have been working on the following activities:
-
Developed new careers in stroke page for the BIASP website with FAQ's and information on all stroke pathways to give an understanding of what a
-
career in stroke means
-
The Trainee's Meeting was in-person held in Edinburgh in March 2024, with 70 delegates attending. There was fantastic feedback on a very successful
-
event. The main sponsor was the Stroke Association.
-
Subcommittee update for the BIASP bulletin
6
British 3nd Irislj Associ3tion of Stroke PhysIcIaS Company Limited by Guarantee Trustees. Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024 Bursarles and compedtlons Warlow Prlze The winner of Ihe BIASP Warlow Prize 2023 wa.£ awarded a certificate and receives supportto attend the annual conference of the European Stroke Conlerence In order to presenL Ihelr prize-wlnnlng research. BIASP Presldent's Award In celehratinn nf BASP'.% 20th AnnIVearY in 2019, we intrf)duced an annual'Pre£ident'.% Award. to reward excellence in clinical £tandard£ (including cllnlcal praciice and/ or qualiiy Improvemenil, tralnlnE and educatlon. and/ or research rel£lied to Stroke Medicine. BIASP member5 are a51ced tu numinate a UK 5truke PhysiLian, who is a BIA5P member, and clemun5trate5 exiellence in clinlcal standard5 IlnclucllnE Ilnlcal practlco andlor quallty improvcmcntl, tralning and educatlon, and/ or rc£carch rclatod trj Strokc Modlclnc. BIASP Medlcal Student Essay Prlze Entrants. rnu5t subinit 250-wurd Lase repurt on a patient they have seen ur been Invulved wlth that has sufferecl a strolce and they have an Importsnt mo.%8agc tf) toll. Tho pri7.c for tho winncr i8 frcc attcndanco at the BIASP Ti'aincc£' mcotingwith thc opptjrtunity trj proscnt thcir casc. BIASP/NIHR Wrldng Group Appllcatlons Th1% ycar, thL, BIASP and thL NIHR RDN..Stri)kL will lulDtly i_4%uL' a ¢all tLb duLtur4, nur%L% allild hLalth prufLI_4%iunal% lur wrltingKruup% ti) %uppurt poril()lio dcvel()pmeni acrnfs tho strokc pathway. A maximum Df £l.DOD pcrwriting rOUP 1£ availahlc. and Thc SirDkc A%%tJciaiiDn havc kindly a81.ccd 10 otlcr thelr prcmlses acros% Iho United Kingdom In tf2clliiaic Ihe.%e wrlting grnup mcciing%. Usually up to two applicc21ioll% Eil'L. lunded, lollDwing peer revlew by representatlves ol the BIASP sclentlfiL commlttee members and the NIHR RDN., Stoke Natlonal SpeLlalty Lead for Stroke. Local Cllnlcal Research Investlgator Award.. umpL'tlliiTrn piliit dL'VL'II)PL'd £ind l£iunLhL'd SL'prember 2023, thls was a suL¢ess and w511 Lunfinue In 2024. ThL, L()Lal Clinlcal RL%Larch InvL%tlkTat()r Award by thL, Brlti.sh and Irl%h A4g()Liatiiin I)fSt)kl, Phy%iLiang IBIASPI aLkn()wlc,dk7LTr4 and rL'ward% thL' exccptiiinal cnntrlhutl()n.4 madL, by %tr()kL' pliy.%lLlan% In %tr()kL' fL'.4L'ar£h. Thi% award alm% tn rL'ii?gni.%L' thL' valuL' nl gi'a%%rn()L4 fL'%L'arili L,ft()rL% and '.11 praLtitl()nL'r.% In rldvaniinE thL. kn()wlL'dklL' and trL'.ItmL'nt ()f 5tr(IkL'. Sustslnablllty competltion atUKSFt poster at BIASP stsnd.. H(IW WL'II di) yiiu kniiw yiiur Larb()n? SLan thL' QR LiidL' ()n thL' P¢l%tL'r to answer thL' qucstltrns wlth wlnnL'r chosL'n at rand(Im. WlnnL'r rL'cclvL'd a c()py of 'Hiiw BAD ArL' Banana%? ThL' Larb()n fiiiitprint (If L'VL'rythln% hy MlkL' BL'rnL'r.%-LL'L'. Other Informadon on BIASP activltles: UK Stroke Forum 2023 UKSF yC¢irly c()nlcrcnLL' In BlrminhTh¢im 2023 hvsted by Strukc A$5uclatlun and BIASP. Womcn In Stroke se5slon run by BIASP ED&1 Icad. BIASP arc rL'prc'sc'ntL,d at thL' UKSF StL'L'rln% CummlttL'L' ML'L,tlnyS and thc, UKSF SclL'ntlflc PruMrammL' LummlttL'c'. Ukralne Tv suppvrtcolleagues d15placed by the war In Ukraine BIASP now offer Iree mernber5hlp whlch allow5 acre55 to all inlormation on the BIASP web51te. BIASP also uffL'r frL'L' attL'ndanLL' ai UKSF for une Ukralnc, Lollc'aKuc'. European Llfv After stroke Fornm, 2024 BIASP offered to pay 71] eKpen5e5 for one member ofany ofthe BIASP EKec or subcommittees to attend this event as it links with the BIASP Strriiegy. AnyvnL' IntL'rL'5tL'd wa5 10 put Ihc'lr Lase furward to 4uaiify. A re4ulrL'mL'nt ru aitL'nd wa5 tts provldL' wrlllL'n fL'L'Libaik tsn the eveni to IhL' L'VL'nt whlih was shared wlth BIASP mcmbcrs vla thc bullctin. UK & ROI Acute Stroke Slmulatlon Course The UK& ROI Aiute Strukv Slmulatlun Cuurse has been developed to provlde standard15ed multlL1I5clpllnary stroke slmulatlon tralnlnK tu healthcare prvFesslvnals airus5 the Unlled Kln%dum and the Republli UF Ireland. It was estsblished In 2023 by s Kruup uFhesltliiare prufessiunals sll wlth an intcrcEt in.troke SiTnulatinn training3nd 3 £liared vision to improvc strnkc tr3inin6 and cduc3tion. It 1£ nur linpc tliat ovcr time Etl.nkc.1mU]atIoll trainingwill become easily accessible to all healthcare professionals across the United Kingdom alld Republic of Irelalld. The BIASP Training & Educaiion chair worked alongside a previous Take up Siroke Fellow to develop the course to be shared IhrougThoui the UK and ROI. FLTrlluwln%SULLessful piluts, the cuurse was launLhed at thE UKSF In DeLembEr 2023 with fuur plannecl dates frum January 2024 unw3rds. Career in Stroke Frequently asked Question5 website page Members of the Trainee subcommiitee developed d new websiie page as a tool to provide guidance for a career in siroke for both Ihe UK and ROI. This paKe provldes relevant Infurmatlun LTrn why consider a iarEer In 5truke, how to becume a stroke phy51clan, whD can apply fur5trDkE sub-5pEclalry trainin& what the trainiiig pathw3y.s Innk likc fni. UK and ROI and Carcer lor.strnkc phy£ician.s. New collaboration with NANSIG (Neurologyand Neurosurgery InterestGroup) Presidentand NANSIG represent3tlves have tnet tu dlscuss huw workln% toTr%ether Lan encuuraKe students Intu careEr In strokE. Pre51dent w35 Invlted to attend thcir cnnfcrcncc in13nuarya£ a.spcakcrand hopcE to build on thc rc13tinnEhip bctwccn hoth org3ni£ation£.
British and Irish Association of Stroke Physicians
Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2024
Financial review
The charity's incoming resources for the year were £126,344 (2023: £139,569) mainly comprising subscription income of £98,154 (2023: £94,486), conference registrations of £16,655 (2023: £19,360) and UK Acute Stroke Simulation Course of £6,408 launched this year. Spending in support of charitable activities was £116,596 (2023: £115,178). Support related costs were £76,975 (2023: £63,156). Governance fees were £4,500 (2023: £4,120). Net surplus for the year of £9,747 (2023: £25,122). Reserves and funds carried forward at 31 March 2024 were £276,407 (2023: £266,660).
Reserves policy
Currently BIASP is required to retain a significant liquid capital reserve to be able to discharge its obligations in underwriting the UK Stroke Forum (see below) without jeopardizing its other activities.
Investment policy
The Honorary Treasurer shall deposit or invest any funds which are not immediately required for the Company's activities in such investments as may be considered appropriate (and to dispose of, and vary, such investments) which may include investing in one or more collective investment scheme(s), such as unit trusts, open ended investment companies or common investment funds for charities. In keeping with the BIASP strategy aims any such investments will be scrutinized to ensure these are compatible climate sustainability.
Risk management
The Trusteees annually review the risks that the charity faces. To date these have mainly related to the Association's joint underwriting of the UK Stroke Forum. This is the premier educational academic and clinical stroke conference in the UK. It seeks to bring together members from medicine, nursing, the therapies and other healthcare professionals to share knowledge and enhance practice in stroke medicine. The Association is responsible for 1/3 of the profit or loss of the overall result from UKSF. Due to increasing costs and events during covid this has resulted in BIASP being responsible for a share of the loss on recent events. The overall conference result is monitored closely by the UKSF steering committee of which BIASP is represented on.
Future plans
The Association remains strategically committed to furthering its broad objectives by whatever appropriate means in accordance with its charitable status. The profile of stroke medicine in the UK has risen sharply, supported by political initiatives such as the English National Stroke Strategy and the equivalent policy documents in the devolved nations of the UK. With this rising profile is a corresponding demand upon the Association to put forward the views of the profession to political bodies, other healthcare professions and the wider public; to liaise with an increasing number of interested national bodies; to support and develop the scientific credibility of the practice of stroke medicine; and to improve the training of physicians in stroke medicine. These demands will continue or increase in the years to come, drawing on the financial and other resources of the Association. Equality Diversity and Inclusion executive member has been developing the BIASP ED&I policy. The application form to be completed when joining BIASP is being reviewed. BIASP wish to accelerate progress in this area to fully understand the equality and diversity of its members to then explore the wider stroke workforce.
Workforce challenges within the UK & ROI will be a major focus for BIASP, they will continue to work towards finding a solution with nation leads for stroke, other stakeholder associations and charities.
Trustee's responsibilities statement:
The trustees, who are also directors for the purposes of company law, are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the charity trustees to prepare financial statements for each year which give a true and fair view of the state of affairs of the charitable company and the incoming resources and application of resources, including the income and expenditure, for the period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the applicable Charities SORP;
-
make judgements and accounting estimates that are reasonable and prudent;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies' exemption. The trustee's annual report was approved on and signed on behalf of the board of trustees by: -
David Werring
Trustee & President
8
British and Irish Association of Stroke Physicians Company Limited by Guarantee Independent examiner's report For the year ended 31 March 2024
I report to the charity trustees on my examination of the financial statements of the Charity for the year ended 31 March 2024.
Respective responsibilities of trustees and examiner
As the charity's trustees of the Company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Basis of independent examiner's report
My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below.
Independent examiner's qualified statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1.accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true an fair view' which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Use of our report
This report is made solely to the charitable company's members and the trustees, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our examination has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an independent examiner's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company, the charitable company's members and trustees as a body, for our examination, for this report, or for the opinions we have formed. Sab Kenneth McDowell CA — Saffery LLP 9 Haymarket Square Chartered Accountants Edinburgh EH3 8RY
2 December 2024
9
British and Irish Association of Stroke Physicians Company Limited by Guarantee
Statement of Financial Activities (including Income and Expenditure account) For the year ended 31 March 2024
| Notes Income and endowments Investment income 3 Charitable activities 4 Total income Expenditure on: Charitable activities 5 Total expenditure Net(expenditure)/income Transfers between funds Total funds brought forward Total funds carried forward 9 |
Unrestricted funds £ 3,210 123,134 126,344 116,596 116,596 9,747 - 266,660 276,407 |
Total funds 2024 £ 3,210 123,134 126,344 116,596 116,596 9,747 - 266,660 276,407 |
Total funds 2023 £ 764 138,805 |
|---|---|---|---|
| 139,569 | |||
| 114,447 | |||
| 114,447 | |||
| 25,122 | |||
| - 241,538 |
|||
| 266,660 |
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
10
British and Irish Association of Stroke Physicians Company Limited by Guarantee Statement of financial position For the year ended 31 March 2024
| 2024 | 2023 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| Current assets | |||||
| Debtors | 7 | 21,724 | 35,108 | ||
| Cash at bank and in hand | 329,395 | 295,437 | |||
| 351,118 | 330,545 | ||||
| Creditors: amounts falling due within one year | 8 | 74,711 | 63,885 | ||
| Net current assets | 276,407 | 266,660 | |||
| Total assets less current liabilities | 276,407 | 266,660 | |||
| Net assets | 276,407 | 266,660 | |||
| Funds of the charity | |||||
| Unrestricted funds | 276,407 | 266,660 | |||
| 9 | 276,407 | 266,660 |
For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
The financial statements were approved by the board of trustees and authorised for issue on 24/11/2024 and are signed on its behalf by:
Dr Elizabeth Warburton
Treasurer
Company Registration No. 06853971
11
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2024
1. Accounting Policies
Company information
The charity is a private company limited by guarantee, registered in England and Wales and a registered charity in England. The address of the registered office is 71 Queen Victoria Street, London, England, EC4V 4BE.
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - Charities SORP (FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
1.2 Going Concern
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3 Income and expenditure
Income representing membership subscriptions, interest and branch income receivable is accounted for on an accruals basis. Donations and gift aid claims are recognised on receipt of proceeds.
Resources expended are included in the statement of financial activities on an accruals basis.
All costs have been directly attributed to one of the functional categories of resources expended in the statement of financial activities as follows:
Charitable activities
These are costs relating to expenditure on preserving and maintaining the assets of the charity and the associated trade.
Other expenditure
These are costs associated with the running of the regional branches of the charity.
1.4 Cash and cash equivalents
Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other shortterm liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
12
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2024
1.5 Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as 'creditors: amounts falling due within one year' if payment is due within one year or less. If not, they are presented as 'creditors: amounts falling due after more than one year'. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.
1.6 Fund accounting
The funds of the charity are held in unrestricted and restricted funds. Unrestricted funds represent funds which can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds represent funds which must be used in accordance with the specific objectives that were laid out by those parties providing the funds to the charity.
13
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2024
1. Accounting Policies (continued)
1.7 Taxation
The company is a registered charity and is not liable for United Kingdom income tax or corporation tax on charitable activities.
2. Limited by guarantee
British and Irish Association of Stroke Physicians is a company limited by guarantee and accordingly does not have share capital. Every member of the company undertakes to contribute such amount as may be required not exceeding £1 to the assets of the charitable company in the event of its being wound up while he or she is a member, or within one year after he or she ceases to be a member.
3. Investment income
| 3. Investment income | |
|---|---|
| Bank interest 4. Charitable activities Membership subscriptions UKSF profit share Trainee conference Sim course |
2024 2023 £ £ 3,210 764 |
| 3,210 764 |
|
| 2024 2023 £ £ 98,154 94,486 1,917 25,690 16,655 19,360 6,408 - |
|
| 123,134 139,536 |
14
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2024
5. Expenditure on charitable activities
| 5. Expenditure on charitable activities | |
|---|---|
| Charitableactivities UKSF attendance costs Events Advertising Website Trainee conference Sponsorships and bursaries Travel & subsistence Donations Insurance Consultancy Printing, postage, advertising & stationery Share of support costs Share of governance Note 7 Support costs Bank charges Professional fees Administrative costs Bookkeeping 7. Independent examination fees Fees payable to the independent examiner for: Independent examination of the financial statements 8. Debtors Trade debtors Prepayments |
2024 2023 £ £ 3,877 4,430 1,847 1,458 803 1,641 1,843 3,690 18,256 20,009 5,724 15,042 911 - 1,588 77 - 1,544 270 - 4 12 76,975 63,156 4,500 4,120 |
| 116,596 115,178 |
|
| 1,028 1,027 1,504 16 65,817 54,525 8,626 7,588 |
|
| 76,975 63,156 |
|
| 2024 2023 £ £ |
|
| 4,500 4,120 |
|
| 2024 2023 £ £ 2,240 1,350 19,484 33,758 |
|
| 21,724 35,108 |
15
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2024
9. Creditors: amounts falling due within one year
| 9. Creditors: amounts falling due within one year | |
|---|---|
| Trade creditors Accruals & deferred income Analysis of deferred income account Memberships Conference receipts |
2024 2023 £ £ 19,044 8,043 55,667 55,842 |
| 74,711 63,885 |
|
| 37,334 36,623 - - |
|
| 37,334 36,623 |
During the year brought forward deferred income of £36,623 was released to the statement of financial activities and a further £37,334 of income was deferred.
- Analysis of charitable funds
| Unrestrictedfunds General funds |
As at 1 April 2023 £ Income £ Expenditure £ 266,660 126,344 (116,596) |
As at 31 March 2024 £ 276,407 |
|---|---|---|
| 266,660 126,344 (116,596) |
276,407 |
11. Transactions with trustees
No trustees received remuneration in the year.
Travel and subsistence expenses reimbursed to trustees or paid directly to third parties totalled £Nil (2023: £Nil).
16
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements
For the year ended 31 March 2024
12. Analysis of net assets between funds
| 12. Analysis of net assets between funds | |
|---|---|
| Current assets Creditors less than 1 year Net assets Comparative analysis of net assets between funds for prior year Current assets Creditors less than 1 year Net assets 13. Comparative Statement of Financial Activities for the year ended 31 March 2022 Income and endowments Income from donations and legacies Charitable activities Total income Expenditure on: Expenditure on charitable activities Total expenditure Net expenditure Transfers between funds Net movement in funds Reconciliation of funds Total funds brought forward Total funds carried forward |
Unrestricted funds Total Funds 2024 £ £ 351,118 351,118 (74,711) (74,711) |
| 276,407 276,407 |
|
| Unrestricted funds Total Funds 2023 £ £ 330,545 330,545 (63,885) (63,885) |
|
| 266,660 266,660 |
|
| Unrestricted funds Total funds 2023 £ £ 764 764 138,805 138,805 |
|
| 139,569 139,569 |
|
| 114,447 114,447 |
|
| 114,447 114,447 |
|
| 25,122 25,122 |
|
| - - |
|
| 25,122 25,122 241,538 241,538 |
|
| 266,660 266,660 |
17
British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2024
14. Company limited by guarantee
The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up while he or she is a member, or within one year after he or she ceases to be a member, is limited to £1.
15. Post balance sheet events and going concern
At the date of approval, the trustees have prepared and approved up to date management accounts, and have also considered future cash flow including key income and cost assumptions that the trustees consider reasonable and prudent.
Having considered the matters above the trustees are of the view that, at the date of approval of the financial statements, the charity will have sufficient resources to continue to operate and meet debts as they fall due for the foreseeable future. The financial statements have therefore been drawn up on a going concern basis.
18